CLINICAL_TRIALS
trial_result
· 2019-09-27
Clinical Trial Update: Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients [Phase 4]
Summary
Phase 4 trial update assessing the effect of tiotropium + olodaterol on breathlessness in COPD patients; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2019-09-27